Market revenue in 2023 | USD 13,673.1 million |
Market revenue in 2030 | USD 29,568.2 million |
Growth rate | 11.6% (CAGR from 2023 to 2030) |
Largest segment | Pharmaceutical industry |
Fastest growing segment | Diagnostics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pharmaceutical Industry, Cosmetics And Household Products, Academic Institutes and Research Laboratories, Diagnostics, Chemicals Industry, Food Industry |
Key market players worldwide | Charles River Laboratories International Inc, SGS, Merck KGaA, Eurofins Scientific SE, Abbott Laboratories, Labcorp Holdings Inc, Evotec SE, Thermo Fisher Scientific Inc, Quest Diagnostics Inc, Agilent Technologies Inc, Catalent Inc, Danaher Corp, Bio-Rad Laboratories Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in-vitro toxicology testing market will help companies and investors design strategic landscapes.
Pharmaceutical industry was the largest segment with a revenue share of 43.25% in 2023. Horizon Databook has segmented the U.S. in-vitro toxicology testing market based on pharmaceutical industry, cosmetics and household products, academic institutes and research laboratories, diagnostics, chemicals industry, food industry covering the revenue growth of each sub-segment from 2018 to 2030.
Competition in the in-vitro toxicology testing market is intense, as companies strive to offer high-quality, cost-effective testing services that meet the needs of their customers. The market is driven by factors such as increased regulatory scrutiny and the growing demand for alternative testing methods. For instance, the FDA Modernization Act 2.0 was unanimously passed by both the U.S.
Researchers and companies are increasingly relying on nonanimal testing methods, such as organ-on-achip technologies, in vitro cell-based assays, and computer modeling, to investigate the mechanisms of diseases and test the efficacy of new drugs.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. in-vitro toxicology testing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. in-vitro toxicology testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account